Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

How to improve neurodevelopmental and quality of life outcomes following early surgery for congenital heart disease?

  • Read more about How to improve neurodevelopmental and quality of life outcomes following early surgery for congenital heart disease?

HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.

  • Read more about HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism.

Chromatin modulators as facilitating factors in cellular reprogramming.

  • Read more about Chromatin modulators as facilitating factors in cellular reprogramming.

A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.

  • Read more about A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.

A 19-year-old man with sickle cell disease presenting with spinal infarction: a case report.

  • Read more about A 19-year-old man with sickle cell disease presenting with spinal infarction: a case report.

Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial.

  • Read more about Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial.

Pharmacometabolomics of statin response.

  • Read more about Pharmacometabolomics of statin response.

High-density lipoproteins: a consensus statement from the National Lipid Association.

  • Read more about High-density lipoproteins: a consensus statement from the National Lipid Association.

De novo mutations in epileptic encephalopathies.

  • Read more about De novo mutations in epileptic encephalopathies.

Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.

  • Read more about Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.

Pagination

  • Previous page ‹‹
  • Page 137
  • Next page ››
Subscribe to

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List